Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials.
Groopman
J D
JD
Department of Environmental Health Sciences, John Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205.
Roebuck
B D
BD
Kensler
T W
TW
D000348:Aflatoxins / Q000378:metabolism; D000818:Animals; D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor; D002273:Carcinogens / Q000032:analysis / Q000378:metabolism*; D004247:DNA / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000378:metabolism / Q000517:prevention & control; D009369:Neoplasms / Q000453:epidemiology; D011506:Proteins / Q000032:analysis / Q000378:metabolism*; D011719:Pyrazines / Q000627:therapeutic use; D013871:Thiones; D013876:Thiophenes
D000348:Aflatoxins; D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor; D002273:Carcinogens; D011506:Proteins; D011719:Pyrazines; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz; D004247:DNA